Mesenchymal Stem Cells: Emerging Therapy for Duchenne Muscular Dystrophy

PM and R

Volumn 1, Issue 6, 2009, Pages 547-559

  Markert, Chad D ^a   Atala, Anthony ^a   Cann, Jennifer K ^a   Christ, George ^a   Furth, Mark ^a   Ambrosio, Fabrisia ^b   Childers, Martin K ^c  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIINFLAMMATORY AGENT; ANTISENSE OLIGODEOXYNUCLEOTIDE; ANTISENSE OLIGONUCLEOTIDE; ARGININE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DYSTROPHIN; FOLLISTATIN; LEUPEPTIN; MYOSTATIN INHIBITOR; NITRIC OXIDE DONOR; PREDNISOLONE; PREDNISONE; PROTEIN INHIBITOR; PROTEINASE INHIBITOR; PTC 124; UNCLASSIFIED DRUG; UTROPHIN;

ADENO ASSOCIATED VIRUS; ADULT STEM CELL; CELL CULTURE; CELL THERAPY; CLINICAL TRIAL; DEVELOPMENTAL BIOLOGY; DNA MODIFICATION; DUCHENNE MUSCULAR DYSTROPHY; EMBRYONIC STEM CELL; GENE MUTATION; GENE TRANSFER; HISTOCOMPATIBILITY; HUMAN; IMMUNE RESPONSE; MESENCHYMAL STEM CELL TRANSPLANTATION; MUSCLE DEVELOPMENT; MYOBLAST; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; PERICYTE; PRIORITY JOURNAL; REVIEW; SATELLITE CELL; STEM CELL EXPANSION; VOCATIONAL REHABILITATION;

ANIMALS; DISEASE MODELS, ANIMAL; GENE THERAPY; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MUSCULAR DYSTROPHY, DUCHENNE;

EID: 67249147702     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2009.02.013     Document Type: Review

References (201)

1. Hoffman E.P., Brown Jr. R.H., and Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51 (1987) 919-928
2. Petrof B.J. The molecular basis of activity-induced muscle injury in Duchenne muscular dystrophy. Mol Cell Biochem 179 (1998) 111-123
3. Petrof B.J. Molecular pathophysiology of myofiber injury in deficiencies of the dystrophin-glycoprotein complex. Am J Phys Med Rehabil 81 (2002) S162-S174
4. Mauro A. Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 9 (1961) 493-495
5. Oexle K., and Kohlschutter A. Cause of progression in Duchenne muscular dystrophy: impaired differentiation more probable than replicative aging. Neuropediatrics 32 (2001) 123-129
6. Lysaght M.J., Jaklenec A., and Deweerd E. Great expectations: private sector activity in tissue engineering, regenerative medicine, and stem cell therapeutics. Tissue Eng Part A 14 (2008) 305-315
7. Daftary A.S., Crisanti M., Kalra M., Wong B., and Amin R. Effect of long-term steroids on cough efficiency and respiratory muscle strength in patients with Duchenne muscular dystrophy. Pediatrics 119 (2007) e320-e324
8. Williams I.A., and Allen D.G. Intracellular calcium handling in ventricular myocytes from mdx mice. Am J Physiol Heart Circ Physiol 292 (2007) H846-H855
9. Nakatani M., Takehara Y., Sugino H., et al. Transgenic expression of a myostatin inhibitor derived from follistatin increases skeletal muscle mass and ameliorates dystrophic pathology in mdx mice. FASEB J 22 (2008) 477-487
10. Wagner K.R., Fleckenstein J.L., Amato A.A., et al. A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol 63 (2008) 561-571
11. Hamed S.A. Drug evaluation: PTC-124-a potential treatment of cystic fibrosis and Duchenne muscular dystrophy. IDrugs 9 (2006) 783-789
12. Hirawat S., Welch E.M., Elfring G.L., et al. Safety, tolerability, and pharmacokinetics of PTC124, a nonaminoglycoside nonsense mutation suppressor, following single- and multiple-dose administration to healthy male and female adult volunteers. J Clin Pharmacol 47 (2007) 430-444
13. Wilton S. PTC124, nonsense mutations and Duchenne muscular dystrophy. Neuromuscul Disord 17 (2007) 719-720
14. Badalamente M.A., and Stracher A. Delay of muscle degeneration and necrosis in mdx mice by calpain inhibition. Muscle Nerve 23 (2000) 106-111
15. Nonaka I., Ishiura S., Takagi A., and Sugita H. Therapeutic trial with protease inhibitor (leupeptin) in chicken muscular dystrophy. A histologic and histochemical study. Acta Neuropathol 58 (1982) 279-285
16. Stracher A. Calpain inhibitors as therapeutic agents in nerve and muscle degeneration. Ann N Y Acad Sci 884 (1999) 52-59
17. Kajimoto H., Ishigaki K., Okumura K., et al. Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy. Circ J 70 (2006) 991-994
18. Tidball J.G., and Wehling-Henricks M. The role of free radicals in the pathophysiology of muscular dystrophy. J Appl Physiol 102 (2007) 1677-1686
19. Brunelli S., Sciorati C., D'Antona G., et al. Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy. Proc Natl Acad Sci U S A 104 (2007) 264-269
20. Zhou G.Q., Xie H.Q., Zhang S.Z., and Yang Z.M. Current understanding of dystrophin-related muscular dystrophy and therapeutic challenges ahead. Chin Med J (Engl) 119 (2006) 1381-1391
21. Sampaolesi M., Blot S., D'Antona G., et al. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444 (2006) 574-579
22. Duan D. Challenges and opportunities in dystrophin-deficient cardiomyopathy gene therapy. Hum Mol Genet 15 (2006) R253-R261 Spec No 2.
23. Rodino-Klapac L.R., Janssen P.M., Montgomery C.L., et al. A translational approach for limb vascular delivery of the micro-dystrophin gene without high volume or high pressure for treatment of Duchenne muscular dystrophy. J Transl Med 5 (2007) 45
24. van Deutekom J.C., Janson A.A., Ginjaar I.B., et al. Local dystrophin restoration with antisense oligonucleotide PRO051. N Engl J Med 357 (2007) 2677-2686
25. Mattei E., Corbi N., Di Certo M.G., et al. Utrophin up-regulation by an artificial transcription factor in transgenic mice. PLoS ONE 2 (2007) e774
26. Bostick B., Yue Y., Long C., and Duan D. Prevention of dystrophin-deficient cardiomyopathy in twenty-one-month-old carrier mice by mosaic dystrophin expression or complementary dystrophin/utrophin expression. Circ Res 102 (2008) 121-130
27. Cerletti M., Negri T., Cozzi F., et al. Dystrophic phenotype of canine X-linked muscular dystrophy is mitigated by adenovirus-mediated utrophin gene transfer. Gene Ther 10 (2003) 750-757
28. Gillis J.M. An attempt of gene therapy in Duchenne muscular dystrophy: overexpression of utrophin in transgenic mdx mice. Acta Neurol Belg 100 (2000) 146-150
29. Hirst R.C., McCullagh K.J., and Davies K.E. Utrophin upregulation in Duchenne muscular dystrophy. Acta Myol 24 (2005) 209-216
30. Odom G.L., Gregorevic P., and Chamberlain J.S. Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances. Biochim Biophys Acta 1772 (2007) 243-262
31. Laird D.J., von Andrian U.H., and Wagers A.J. Stem cell trafficking in tissue development, growth, and disease. Cell 132 (2008) 612-630
32. Price F.D., Kuroda K., and Rudnicki M.A. Stem cell based therapies to treat muscular dystrophy. Biochim Biophys Acta 1772 (2007) 272-283
33. Huard J., Cao B., and Qu-Petersen Z. Muscle-derived stem cells: potential for muscle regeneration. Birth Defects Res C Embryo Today 69 (2003) 230-237
34. Borycki A.G., Brunk B., Tajbakhsh S., Buckingham M., Chiang C., and Emerson Jr. C.P. Sonic hedgehog controls epaxial muscle determination through Myf5 activation. Development 126 (1999) 4053-4063
35. Cossu G. Fusion of bone marrow-derived stem cells with striated muscle may not be sufficient to activate muscle genes. J Clin Invest 114 (2004) 1540-1543
36. Maltin C.A., Delday M.I., Sinclair K.D., Steven J., and Sneddon A.A. Impact of manipulations of myogenesis in utero on the performance of adult skeletal muscle. Reproduction 122 (2001) 359-374
37. Christ B., and Brand-Saberi B. Limb muscle development. Int J Dev Biol 46 (2002) 905-914
38. Relaix F. Skeletal muscle progenitor cells: from embryo to adult. Cell Mol Life Sci 63 (2006) 1221-1225
39. Haberland M., Arnold M.A., McAnally J., Phan D., Kim Y., and Olson E.N. Regulation of HDAC9 gene expression by MEF2 establishes a negative-feedback loop in the transcriptional circuitry of muscle differentiation. Mol Cell Biol 27 (2007) 518-525
40. Buckingham M. Muscle differentiation. Which myogenic factors make muscle?. Curr Biol 4 (1994) 61-63
41. Buckingham M., Bajard L., Chang T., et al. The formation of skeletal muscle: from somite to limb. J Anat 202 (2003) 59-68
42. Shi X., and Garry D.J. Muscle stem cells in development, regeneration, and disease. Genes Dev 20 (2006) 1692-1708
43. Cossu G., and Borello U. Wnt signaling and the activation of myogenesis in mammals. EMBO J 18 (1999) 6867-6872
44. Yen B.L., Huang H.I., Chien C.C., et al. Isolation of multipotent cells from human term placenta. Stem Cells 23 (2005) 3-9
45. Wagers A.J., Christensen J.L., and Weissman I.L. Cell fate determination from stem cells. Gene Ther 9 (2002) 606-612
46. Kuang S., Gillespie M.A., and Rudnicki M.A. Niche regulation of muscle satellite cell self-renewal and differentiation. Cell Stem Cell 2 (2008) 22-31
47. Caplan A.I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213 (2007) 341-347
48. Thomas E.D., Lochte Jr. H.L., Lu W.C., and Ferrebee J.W. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med 257 (1957) 491-496
49. Ema H., Morita Y., Yamazaki S., et al. Adult mouse hematopoietic stem cells: purification and single-cell assays. Nat Protoc 1 (2006) 2979-2987
50. Cao Y.A., Wagers A.J., Beilhack A., et al. Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc Natl Acad Sci U S A 101 (2004) 221-226
51. Bryder D., Rossi D.J., and Weissman I.L. Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. Am J Pathol 169 (2006) 338-346
52. Schoemans H., Theunissen K., Maertens J., Boogaerts M., Verfaillie C., and Wagner J. Adult umbilical cord blood transplantation: a comprehensive review. Bone Marrow Transplant 38 (2006) 83-93
53. Broxmeyer H.E., Douglas G.W., Hangoc G., et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A 86 (1989) 3828-3832
54. Potten C.S., and Loeffler M. Stem cells: attributes, cycles, spirals, pitfalls and uncertainties. Lessons for and from the crypt. Development 110 (1990) 1001-1020
55. Giannakis M., Stappenbeck T.S., Mills J.C., et al. Molecular properties of adult mouse gastric and intestinal epithelial progenitors in their niches. J Biol Chem 281 (2006) 11292-11300
56. Dekaney C.M., Rodriguez J.M., Graul M.C., and Henning S.J. Isolation and characterization of a putative intestinal stem cell fraction from mouse jejunum. Gastroenterology 129 (2005) 1567-1580
57. Blanpain C., and Fuchs E. Epidermal stem cells of the skin. Annu Rev Cell Dev Biol 22 (2006) 339-373
58. Weissman I.L., Anderson D.J., and Gage F. Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. Annu Rev Cell Dev Biol 17 (2001) 387-403
59. Metcalf D. Concise review: hematopoietic stem cells and tissue stem cells: current concepts and unanswered questions. Stem Cells 25 (2007) 2390-2395
60. Jiang Y., Vaessen B., Lenvik T., Blackstad M., Reyes M., and Verfaillie C.M. Multipotent progenitor cells can be isolated from postnatal murine bone marrow, muscle, and brain. Exp Hematol 30 (2002) 896-904
61. Presnell S.C., Petersen B., and Heidaran M. Stem cells in adult tissues. Semin Cell Dev Biol 13 (2002) 369-376
62. Gage F.H. Mammalian neural stem cells. Science 287 (2000) 1433-1438
63. Anversa P., Kajstura J., Leri A., and Bolli R. Life and death of cardiac stem cells: a paradigm shift in cardiac biology. Circulation 113 (2006) 1451-1463
64. Crisan M., Yap S., Casteilla L., et al. A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human Organs. Cell Stem Cell 3 (2008) 301-313
65. Gimble J., and Guilak F. Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy 5 (2003) 362-369
66. Caplan A.I. Mesenchymal stem cells. J Orthop Res 9 (1991) 641-650
67. Caplan A.I. The mesengenic process. Clin Plast Surg 21 (1994) 429-435
68. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276 (1997) 71-74
69. Friedenstein A.J., Gorskaja J.F., and Kulagina N.N. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 4 (1976) 267-274
70. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
71. Pittenger M., Vanguri P., Simonetti D., and Young R. Adult mesenchymal stem cells: potential for muscle and tendon regeneration and use in gene therapy. J Musculoskelet Neuronal Interact 2 (2002) 309-320
72. Aggarwal S., and Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105 (2005) 1815-1822
73. Alviano F., Fossati V., Marchionni C., et al. Term Amniotic membrane is a high throughput source for multipotent Mesenchymal Stem Cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol 7 (2007) 11
74. Fox J.M., Chamberlain G., Ashton B.A., and Middleton J. Recent advances into the understanding of mesenchymal stem cell trafficking. Br J Haematol 137 (2007) 491-502
75. Gawronska-Kozak B., Manuel J.A., and Prpic V. Ear mesenchymal stem cells (EMSC) can differentiate into spontaneously contracting muscle cells. J Cell Biochem 102 (2007) 122-135
76. Jackson L., Jones D.R., Scotting P., and Sottile V. Adult mesenchymal stem cells: differentiation potential and therapeutic applications. J Postgrad Med 53 (2007) 121-127
77. Rodriguez A.M., Pisani D., Dechesne C.A., et al. Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse. J Exp Med 201 (2005) 1397-1405
78. Schrepfer S., Deuse T., Lange C., et al. Simplified protocol to isolate, purify, and culture expand mesenchymal stem cells. Stem Cells Dev 16 (2007) 105-107
79. Soncini M., Vertua E., Gibelli L., et al. Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med 1 (2007) 296-305
80. Tavian M., and Peault B. Embryonic development of the human hematopoietic system. Int J Dev Biol 49 (2005) 243-250
81. Parolini O., Alviano F., Bagnara G.P., et al. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 26 (2008) 300-311
82. Peault B., Rudnicki M., Torrente Y., et al. Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther 15 (2007) 867-877
83. Hughes S.M., and Blau H.M. Migration of myoblasts across basal lamina during skeletal muscle development. Nature 345 (1990) 350-353
84. Yokota T., Lu Q.L., Morgan J.E., et al. Expansion of revertant fibers in dystrophic mdx muscles reflects activity of muscle precursor cells and serves as an index of muscle regeneration. J Cell Sci 119 (2006) 2679-2687
85. Christov C., Chretien F., bou-Khalil R., et al. Muscle satellite cells and endothelial cells: close neighbors and privileged partners. Mol Biol Cell 18 (2007) 1397-1409
86. De Angelis L., Berghella L., Coletta M., et al. Skeletal myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal muscle growth and regeneration. J Cell Biol 147 (1999) 869-878
87. Dellavalle A., Sampaolesi M., Tonlorenzi R., et al. Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol 9 (2007) 255-267
88. Ramirez M., Lucia A., Gomez-Gallego F., et al. Mobilisation of mesenchymal cells into blood in response to skeletal muscle injury. Br J Sports Med 40 (2006) 719-722
89. Sampaolesi M., Torrente Y., Innocenzi A., et al. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 301 (2003) 487-492
90. Traktuev D.O., Merfeld-Clauss S., Li J., et al. A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res 102 (2008) 77-85
91. Kardon G., Campbell J.K., and Tabin C.J. Local extrinsic signals determine muscle and endothelial cell fate and patterning in the vertebrate limb. Dev Cell 3 (2002) 533-545
92. Chamberlain G., Fox J., Ashton B., and Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25 (2007) 2739-2749
93. Montarras D., Morgan J., Collins C., et al. Direct isolation of satellite cells for skeletal muscle regeneration. Science 309 (2005) 2064-2067
94. Parenteau N.L., Nolte C.M., Bilbo P., et al. Epidermis generated in vitro: practical considerations and applications. J Cell Biochem 45 (1991) 245-251
95. Oberpenning F., Meng J., Yoo J.J., and Atala A. De novo reconstitution of a functional mammalian urinary bladder by tissue engineering. Nat Biotechnol 17 (1999) 149-155
96. Uchida N., Buck D.W., He D., et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A 97 (2000) 14720-14725
97. Gage F.H. Mammalian neural stem cells. Science 287 (2000) 1433-1438
98. Weiss S., Reynolds B.A., Vescovi A.L., Morshead C., Craig C.G., and van der Kooy D. Is there a neural stem cell in the mammalian forebrain?. Trends Neurosci 19 (1996) 387-393
99. Schmelzer E., Zhang L., Bruce A., et al. Human hepatic stem cells from fetal and postnatal donors. J Exp Med 204 (2007) 1973-1987
100. Wauthier E., Schmelzer E., Turner W., et al. Hepatic stem cells and hepatoblasts: identification, isolation, and ex vivo maintenance. Methods Cell Biol 86 (2008) 137-225
101. Turner W.S., Seagle C., Galanko J.A., et al. Nuclear magnetic resonance metabolomic footprinting of human hepatic stem cells and hepatoblasts cultured in hyaluronan-matrix hydrogels. Stem Cells 26 (2008) 1547-1555
102. Kubota H., Avarbock M.R., and Brinster R.L. Growth factors essential for self-renewal and expansion of mouse spermatogonial stem cells. Proc Natl Acad Sci U S A 101 (2004) 16489-16494
103. Pittenger M., Vanguri P., Simonetti D., and Young R. Adult mesenchymal stem cells: potential for muscle and tendon regeneration and use in gene therapy. J Musculoskelet Neuronal Interact 2 (2002) 309-320
104. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276 (1997) 71-74
105. Toma C., Pittenger M.F., Cahill K.S., Byrne B.J., and Kessler P.D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105 (2002) 93-98
106. Sampaolesi M., Blot S., D'Antona G., et al. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444 (2006) 574-579
107. Jackson L., Jones D.R., Scotting P., and Sottile V. Adult mesenchymal stem cells: differentiation potential and therapeutic applications. J Postgrad Med 53 (2007) 121-127
108. Mizuno H., and Hyakusoku H. Mesengenic potential and future clinical perspective of human processed lipoaspirate cells. J Nippon Med Sch 70 (2003) 300-306
109. Barberi T., Willis L.M., Socci N.D., and Studer L. Derivation of multipotent mesenchymal precursors from human embryonic stem cells. PLoS Med 2 (2005) e161
110. Wise C.J., Watt D.J., and Jones G.E. Conversion of dermal fibroblasts to a myogenic lineage is induced by a soluble factor derived from myoblasts. J Cell Biochem 61 (1996) 363-374
111. Chan J., O'Donoghue K., de la Fuente J., et al. Human fetal mesenchymal stem cells as vehicles for gene delivery. Stem Cells 23 (2005) 93-102
112. Mizuno H., and Hyakusoku H. Mesengenic potential and future clinical perspective of human processed lipoaspirate cells. J Nippon Med Sch 70 (2003) 300-306
113. Li Y., Zhang C., Xiong F., et al. Comparative study of mesenchymal stem cells from C57BL/10 and mdx mice. BMC Cell Biol 9 (2008) 24
114. Barberi T., Bradbury M., Dincer Z., Panagiotakos G., Socci N.D., and Studer L. Derivation of engraftable skeletal myoblasts from human embryonic stem cells. Nat Med 13 (2007) 642-648
115. Chan J., O'Donoghue K., Gavina M., et al. Galectin-1 induces skeletal muscle differentiation in human fetal mesenchymal stem cells and increases muscle regeneration. Stem Cells 24 (2006) 1879-1891
116. Di Rocco G., Iachininoto M.G., Tritarelli A., et al. Myogenic potential of adipose-tissue-derived cells. J Cell Sci 119 (2006) 2945-2952
117. Gang E.J., Jeong J.A., Hong S.H., et al. Skeletal myogenic differentiation of mesenchymal stem cells isolated from human umbilical cord blood. Stem Cells 22 (2004) 617-624
118. Zuk P.A., Zhu M., Mizuno H., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7 (2001) 211-228
119. Invernici G., Emanueli C., Madeddu P., et al. Human fetal aorta contains vascular progenitor cells capable of inducing vasculogenesis, angiogenesis, and myogenesis in vitro and in a murine model of peripheral ischemia. Am J Pathol 170 (2007) 1879-1892
120. Shang Y.C., Wang S.H., Xiong F., et al. Wnt3a signaling promotes proliferation, myogenic differentiation, and migration of rat bone marrow mesenchymal stem cells. Acta Pharmacol Sin 28 (2007) 1761-1774
121. Singh R., Artaza J.N., Taylor W.E., Gonzalez-Cadavid N.F., and Bhasin S. Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology 144 (2003) 5081-5088
122. Shefer G., Wleklinski-Lee M., and Yablonka-Reuveni Z. Skeletal muscle satellite cells can spontaneously enter an alternative mesenchymal pathway. J Cell Sci 117 (2004) 5393-5404
123. Engler A.J., Sen S., Sweeney H.L., and Discher D.E. Matrix elasticity directs stem cell lineage specification. Cell 126 (2006) 677-689
124. Engler A.J., Sweeney H.L., Discher D.E., and Schwarzbauer J.E. Extracellular matrix elasticity directs stem cell differentiation. J Musculoskelet Neuronal Interact 7 (2007) 335
125. Liu Y., Yan X., Sun Z., et al. Flk-1+ adipose-derived mesenchymal stem cells differentiate into skeletal muscle satellite cells and ameliorate muscular dystrophy in mdx mice. Stem Cells Dev 16 (2007) 695-706
126. Bossolasco P., Corti S., Strazzer S., et al. Skeletal muscle differentiation potential of human adult bone marrow cells. Exp Cell Res 295 (2004) 66-78
127. Dezawa M., Ishikawa H., Itokazu Y., et al. Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 309 (2005) 314-317
128. Ferrari G., Cusella-De Angelis G., Coletta M., et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279 (1998) 1528-1530
129. Wakitani S., Saito T., and Caplan A.I. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18 (1995) 1417-1426
130. Zuk P.A., Zhu M., Mizuno H., et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7 (2001) 211-228
131. Liu Y., Yan X., Sun Z., et al. Flk-1+ adipose-derived mesenchymal stem cells differentiate into skeletal muscle satellite cells and ameliorate muscular dystrophy in mdx mice. Stem Cells Dev 16 (2007) 695-706
132. De Coppi P., Bartsch Jr. G., Siddiqui M.M., et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25 (2007) 100-106
133. In't Anker P.S., Scherjon S.A., Kleijburg-van der Keur C., et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 102 (2003) 1548-1549
134. Kaviani A., Perry T.E., Dzakovic A., Jennings R.W., Ziegler M.M., and Fauza D.O. The amniotic fluid as a source of cells for fetal tissue engineering. J Pediatr Surg 36 (2001) 1662-1665
135. Kunisaki S.M., Armant M., Kao G.S., Stevenson K., Kim H., and Fauza D.O. Tissue engineering from human mesenchymal amniocytes: a prelude to clinical trials. J Pediatr Surg 42 (2007) 974-979
136. Trelford J.D., and Trelford-Sauder M. The amnion in surgery, past and present. Am J Obstet Gynecol 134 (1979) 833-845
137. Bili C., Divane A., Apessos A., et al. Prenatal diagnosis of common aneuploidies using quantitative fluorescent PCR. Prenat Diagn 22 (2002) 360-365
138. Torricelli F., Brizzi L., Bernabei P.A., et al. Identification of hematopoietic progenitor cells in human amniotic fluid before the 12th week of gestation. Ital J Anat Embryol 98 (1993) 119-126
139. Wakitani S., Saito T., and Caplan A.I. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18 (1995) 1417-1426
140. Muguruma Y., Reyes M., Nakamura Y., et al. In vivo and in vitro differentiation of myocytes from human bone marrow-derived multipotent progenitor cells. Exp Hematol 31 (2003) 1323-1330
141. Bianco P., and Gehron R.P. Marrow stromal stem cells. J Clin Invest 105 (2000) 1663-1668
142. Bianco P., Robey P.G., and Simmons P.J. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2 (2008) 313-319
143. Gawronska-Kozak B., Manuel J.A., and Prpic V. Ear mesenchymal stem cells (EMSC) can differentiate into spontaneously contracting muscle cells. J Cell Biochem 102 (2007) 122-135
144. Chan J., Waddington S.N., O'Donoghue K., et al. Widespread distribution and muscle differentiation of human fetal mesenchymal stem cells after intrauterine transplantation in dystrophic mdx mouse. Stem Cells 25 (2007) 875-884
145. De Bari C., Dell'Accio F., Tylzanowski P., and Luyten F.P. Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 44 (2001) 1928-1942
146. Caplan A.I. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213 (2007) 341-347
147. Chamberlain G., Fox J., Ashton B., and Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25 (2007) 2739-2749
148. Chang C.J., Yen M.L., Chen Y.C., et al. Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma. Stem Cells 24 (2006) 2466-2477
149. Nauta A.J., and Fibbe W.E. Immunomodulatory properties of mesenchymal stromal cells. Blood 110 (2007) 3499-3506
150. Wolbank S., Peterbauer A., Fahrner M., et al. Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng 13 (2007) 1173-1183
151. Wolf D., and Wolf A.M. Mesenchymal stem cells as cellular immunosuppressants. Lancet 371 (2008) 1553-1554
152. Le Blanc K., Tammik C., Rosendahl K., Zetterberg E., and Ringden O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31 (2003) 890-896
153. Niederkorn J.Y. See no evil, hear no evil, do no evil: the lessons of immune privilege. Nat Immunol 7 (2006) 354-359
154. Mahmood A., Lu D., Lu M., and Chopp M. Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery 53 (2003) 697-702
155. Chen J., Li Y., Wang L., et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32 (2001) 1005-1011
156. Berry M.F., Engler A.J., Woo Y.J., et al. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol 290 (2006) H2196-H2203
157. Iyer S.S., and Rojas M. Anti-inflammatory effects of mesenchymal stem cells: novel concept for future therapies. Expert Opin Biol Ther 8 (2008) 569-581
158. Uccelli A., Pistoia V., and Moretta L. Mesenchymal stem cells: a new strategy for immunosuppression?. Trends Immunol 28 (2007) 219-226
159. Ferrari G., Cusella-De A.G., Coletta M., et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 279 (1998) 1528-1530
160. Gawronska-Kozak B., Manuel J.A., and Prpic V. Ear mesenchymal stem cells (EMSC) can differentiate into spontaneously contracting muscle cells. J Cell Biochem 102 (2007) 122-135
161. Ilancheran S., Michalska A., Peh G., Wallace E.M., Pera M., and Manuelpillai U. Stem cells derived from human fetal membranes display multilineage differentiation potential. Biol Reprod 77 (2007) 577-588
162. Jackson L., Jones D.R., Scotting P., and Sottile V. Adult mesenchymal stem cells: differentiation potential and therapeutic applications. J Postgrad Med 53 (2007) 121-127
163. Kunisaki S.M., Armant M., Kao G.S., Stevenson K., Kim H., and Fauza D.O. Tissue engineering from human mesenchymal amniocytes: a prelude to clinical trials. J Pediatr Surg 42 (2007) 974-979
164. Liu Y., Yan X., Sun Z., et al. Flk-1+ adipose-derived mesenchymal stem cells differentiate into skeletal muscle satellite cells and ameliorate muscular dystrophy in mdx mice. Stem Cells Dev 16 (2007) 695-706
165. Qu-Petersen Z., Deasy B., Jankowski R., et al. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol 157 (2002) 851-864
166. Tamagawa T., Oi S., Ishiwata I., Ishikawa H., and Nakamura Y. Differentiation of mesenchymal cells derived from human amniotic membranes into hepatocyte-like cells in vitro. Hum Cell 20 (2007) 77-84
167. Zhao P., Ise H., Hongo M., Ota M., Konishi I., and Nikaido T. Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation 79 (2005) 528-535
168. Goncalves M.A., Swildens J., Holkers M., et al. Genetic complementation of human muscle cells via directed stem cell fusion. Mol Ther 16 (2008) 741-748
169. Laird D.J., von Andrian U.H., and Wagers A.J. Stem cell trafficking in tissue development, growth, and disease. Cell 132 (2008) 612-630
170. Kobinger G.P., Louboutin J.P., Barton E.R., Sweeney H.L., and Wilson J.M. Correction of the dystrophic phenotype by in vivo targeting of muscle progenitor cells. Hum Gene Ther 14 (2003) 1441-1449
171. Bertoni C., and Rando T.A. Dystrophin gene repair in mdx muscle precursor cells in vitro and in vivo mediated by RNA-DNA chimeric oligonucleotides. Hum Gene Ther 13 (2002) 707-718
172. Bujold M., Caron N., Camiran G., et al. Autotransplantation in mdx mice of mdx myoblasts genetically corrected by an HSV-1 amplicon vector. Cell Transplant 11 (2002) 759-767
173. Li S., Kimura E., Fall B.M., et al. Stable transduction of myogenic cells with lentiviral vectors expressing a minidystrophin. Gene Ther 12 (2005) 1099-1108
174. Quenneville S.P., Chapdelaine P., Skuk D., et al. Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models. Mol Ther 15 (2007) 431-438
175. Xiong F., Xiao S., Peng F., et al. Herpes simplex virus VP22 enhances adenovirus-mediated microdystrophin gene transfer to skeletal muscles in dystrophin-deficient (mdx) mice. Hum Gene Ther 18 (2007) 490-501
176. Bailo M., Soncini M., Vertua E., et al. Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation 78 (2004) 1439-1448
177. Koc O.N., Gerson S.L., Cooper B.W., et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 18 (2000) 307-316
178. Schenk S., Mal N., Finan A., et al. Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem Cells 25 (2007) 245-251
179. Seeger F.H., Zeiher A.M., and Dimmeler S. Cell-enhancement strategies for the treatment of ischemic heart disease. Nat Clin Pract Cardiovasc Med 4 (2007) S110-S113
180. Shyu W.C., Lee Y.J., Liu D.D., Lin S.Z., and Li H. Homing genes, cell therapy and stroke. Front Biosci 11 (2006) 899-907
181. Voermans C., van Hennik P.B., and van der Schoot C.E. Homing of human hematopoietic stem and progenitor cells: new insights, new challenges?. J Hematother Stem Cell Res 10 (2001) 725-738
182. Bachrach E., Perez A.L., Choi Y.H., et al. Muscle engraftment of myogenic progenitor cells following intraarterial transplantation. Muscle Nerve 34 (2006) 44-52
183. Sampaolesi M., Torrente Y., Innocenzi A., et al. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 301 (2003) 487-492
184. Sampaolesi M., Blot S., D'Antona G., et al. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444 (2006) 574-579
185. Torrente Y., Tremblay J.P., Pisati F., et al. Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice. J Cell Biol 152 (2001) 335-348
186. Torrente Y., Camirand G., Pisati F., et al. Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy model. J Cell Biol 162 (2003) 511-520
187. Urbich C., and Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95 (2004) 343-353
188. Hogaboam C.M., Carpenter K.J., Schuh J.M., Proudfoot A.A., Bridger G., and Buckland K.F. The therapeutic potential in targeting CCR5 and CXCR4 receptors in infectious and allergic pulmonary disease. Pharmacol Ther 107 (2005) 314-328
189. Laird D.J., von Andrian U.H., and Wagers A.J. Stem cell trafficking in tissue development, growth, and disease. Cell 132 (2008) 612-630
190. Bailo M., Soncini M., Vertua E., et al. Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation 78 (2004) 1439-1448
191. Ueta M., Kweon M.N., Sano Y., et al. Immunosuppressive properties of human amniotic membrane for mixed lymphocyte reaction. Clin Exp Immunol 129 (2002) 464-470
192. Kim J.C., and Tseng S.C. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea 14 (1995) 473-484
193. Trelford J.D., and Trelford-Sauder M. The amnion in surgery, past and present. Am J Obstet Gynecol 134 (1979) 833-845
194. Meisel R., Zibert A., Laryea M., Gobel U., Daubener W., and Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103 (2004) 4619-4621
195. Munn D.H., Zhou M., Attwood J.T., et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281 (1998) 1191-1193
196. Galvez B.G., Sampaolesi M., Brunelli S., et al. Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability. J Cell Biol 174 (2006) 231-243
197. Meisel R., Zibert A., Laryea M., Gobel U., Daubener W., and Dilloo D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103 (2004) 4619-4621
198. Straino S., Germani A., Di Carlo A., et al. Enhanced arteriogenesis and wound repair in dystrophin-deficient mdx mice. Circulation 110 (2004) 3341-3348
199. Brunelli S., Sciorati C., D'Antona G., et al. Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy. Proc Natl Acad Sci U S A 104 (2007) 264-269
200. Palermo A.T., LaBarge M.A., Doyonnas R., Pomerantz J., and Blau H.M. Bone marrow contribution to skeletal muscle: a physiological response to stress. Dev Biol 279 (2005) 336-344
201. Ambrosio F., Ferrari R.J., Fitzgerald G.K., Carvell G.E., Boninger M.L., and Huard J. Functional overloading of dystrophic mice enhances muscle-derived stem cell contribution to muscle contractile capacity. Arch Phys Med Rehab 90 (2009) 66-73